Breaking News, Collaborations & Alliances

Moderna, Generation Bio Partner to Develop Non-Viral Genetic Medicines

Aims to expand the application of each company's platform by developing novel nucleic acid therapeutics, including those capable of reaching immune cells.

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Generation Bio Co., a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, entered into a strategic collaboration to combine Moderna’s biological and technical expertise with core technologies of Generation Bio’s non-viral genetic medicine platform. The collaboration aims to expand the application of each company’s platform by...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters